NEW YORK/LONDON, Jan 8 (Reuters) – Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after agreeing to cut U. pricing last year under pressure from President Donald Trump.
NEW YORK/LONDON, Jan 8 (Reuters) – Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after agreeing to cut U. pricing last year under pressure from President Donald Trump.